Makary US FDA Nomination Advances, Last Minute Hiccup May Offer Clues On Mifepristone

 
• By Sarah Karlin-Smith

President Trump’s CDC director nominee was pulled after vaccine positions appeared too extreme for some Republicans, but the nominations to lead the FDA and NIH advanced to the Senate floor despite last-minute drama.

Sen. Josh Hawley, R-MO, speaks about the resignation of Hilary Perkins as FDA chief counsel. (Screenshot of Senate Broadcast)

More from US FDA

More from Vaccines